APA board appoints clinical treatment guidelines advisory steering committee members

2010 ◽  
Keyword(s):  
Treatment Guidelines ◽  
Steering Committee ◽  
Clinical Treatment

Canadian Guidelines for the Management of Plaque Psoriasis: Overview

2011 ◽  
Vol 15 (4) ◽  
pp. 210-219 ◽  
Author(s):  
Kim Papp ◽  
Wayne Gulliver ◽  
Charles Lynde ◽  
Yves Poulin ◽  
John Ashkenas
Keyword(s):  
Plaque Psoriasis ◽  
Treatment Guidelines ◽  
Treatment Recommendations ◽  
Clinical Treatment ◽  
Evidence Based ◽  
Corporate Sponsors

New clinical treatment guidelines for plaque psoriasis, written by a panel of 16 Canadian dermatologists, were recently published online. These Canadian Guidelines for the Management of Plaque Psoriasis are evidence based and free of any influence from corporate sponsors and have been endorsed by the Canadian Dermatology Association (CDA). The Guidelines offer treatment recommendations for mild and moderate to severe body psoriasis, as well as for psoriasis affecting specific areas of the skin, such as the facial, flexural, and genital areas; nails; scalp; and palms and soles. The present overview describes the genesis and contents of the Guidelines, which are available in full through the CDA at (English) or (French).

scholarly journals Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010

2011 ◽  
Vol 16 (6) ◽  
Author(s):  
M Unemo ◽  
D Golparian ◽  
A Hestner
Keyword(s):  
Case Management ◽  
Treatment Failure ◽  
Treatment Guidelines ◽  
Clinical Treatment ◽  
Empirical Treatment ◽  
First Line ◽  
Line Drug

This report describes one case of verified treatment failure of pharyngeal gonorrhoea using ceftriaxone in Sweden. Previous reports described verified treatment failure of urogenital gonorrhoea using the internationally recommended first-line drug cefixime, but not with ceftriaxone, the last remaining option for empirical treatment of gonorrhoea. Enhanced awareness of clinical failures, pharmacodynamic considerations, follow-up and test of cure, adherence to appropriate case management and treatment guidelines as well as verification/falsification of presumed clinical treatment failures should be emphasised worldwide.

scholarly journals Equity in Cancer Care: Pathways, Protocols, and Guidelines

2012 ◽  
Vol 10 (Suppl_1) ◽  
pp. S-1-S-9 ◽  
Author(s):  
Jessica K. DeMartino ◽  
Jonathan K. Larsen
Keyword(s):  
Patient Care ◽  
Cancer Care ◽  
Treatment Guidelines ◽  
Clinical Pathways ◽  
Insurance Coverage ◽  
Geographic Location ◽  
Clinical Treatment ◽  
Care Pathways ◽  
Treatment Protocols

The quality of patient care varies based on numerous factors, such as health care setting, geographic location, access to medications, insurance coverage, and treatment protocols. Recently, the issue of whether use of clinical pathways can reduce costs and inappropriate variability in care has been the subject of much debate. As clinical treatment guidelines and pathways are increasingly deployed in oncology practice, they have a growing impact on the quality of treatment and how it is delivered. To fulfill the current need to discuss the use of pathways and clinical treatment guidelines in oncology and to address how patient care is impacted by their use, the National Comprehensive Cancer Network convened the NCCN Oncology Policy Summit: Equity in Cancer Care–Pathways, Protocols, and Guidelines. The summit was a forum to discuss the use and implementation of pathways, including how much flexibility pathways should allow in care, pathways’ impact on public and private health insurance benefit design, what data is used to select pathway regimens and protocols, and ultimately what impact pathways may have on variation in care. The use and implementation of clinical treatment guidelines in practice was also explored from a variety of perspectives.

Sign in / Sign up

Export Citation Format

Share Document